|WSMI is pleased to announce that Zhenyu Guo, Ph. D., Chairman and CEO of Dihon Pharmaceutical Co. Ltd., Kunming, China, has taken up the WSMI Chairmanship. Dr Guo had been elected Chairman-Elect of the World Self Medication Industry by the WSMI Board in September 2010. He succeeds Mr Christopher Combe, President and Chairman of Combe Incorporated, USA, who will remain on the WSMI Board as Immediate Past Chairman. The Board of WSMI would like to warmly thank Mr Combe for his chairmanship between 2008 and 2011.|
Dr Guo has been the Chairman and CEO of Dihon Pharmaceuticals since January 2003. Prior to joining Dihon Pharma he was tenured Professor in Electrical Engineering Department and Director of the Laboratory of Biomedical Engineering, The George Washington University, Washington DC, USA. Dr. Guo holds a Ph. D. in Electrical Engineering of McGill University, Canada (1993) and a M.S. in Electrical Engineering of Yunnan University, China (1986). He conducted post-doctoral research in Biomedical Engineering in Western Ontario University, Canada.
Dr Guo is also Vice President of the China Nonprescription Medicine Association (CNMA), WSMI’s member association in China, Vice President of the Yunnan Licensed Pharmacist Association and Vice President of the Yunnan Private Entrepreneur Association. He has received a considerable number of academic and business awards including the “China Outstanding Entrepreneur Award” (2007), the “Outstanding Award for the Development of China’s Self-Medication Industry” (2009) , the “Person of the Year of Chinese Pharmaceutical Industry” (2009), and the “Confucius Entrepreneur Award”(2011).